–
Lisata Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.1
FY22:
−57.6
FY23:
−25.7
FY24:
−22.4
FY25:
−18.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.1
FY22:
−58.6
FY23:
−28.2
FY24:
−24.1
FY25:
−18.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.0
FY22:
−56.7
FY23:
−23.2
FY24:
−20.8
FY25:
−17.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−27.5
FY22:
−54.2
FY23:
−20.8
FY24:
−20.0
FY25:
−16.6
All amounts in millions USD